STORZ & BICKEL Announces New Limited Edition VOLCANO ONYX, Enhanced CRAFTY+ and First-Ever MIGHTY+
TUTTLINGEN, Germany STORZ & BICKEL GmbH, a subsidiary of company Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC), today announced the release of three new vaporizer updates: the limited edition VOLCANO ONYX, the enhanced CRAFTY+, and the first-ever MIGHTY+in the vaporizer industry.
“STORZ & BICKEL has spent the past 20 years developing the world’s most prestigious vaporizer models, consistently defining and refining the gold standard of consumer safety and best-in-class performance,” said Jürgen Bickel, Founder and Managing Director, STORZ & BICKEL.
“We’re raising the bar for the industry once more with an innovative approach to an iconic lineup, featuring the entirely new VOLCANO model alongside upgrades to the most sought-after handheld vaporizers to deliver what connoisseurs and collectors value most: an unmatched vaporization experience.”
The highly anticipated new lineup features the following upgrades:
- VOLCANO HYBRID ONYX Edition: $699; VOLCANO CLASSIC ONYX Edition: $479
The STORZ & BICKEL desktop VOLCANO CLASSIC and VOLCANO HYBRID get a limited-edition luxury update, with a sleek matte black exterior, finished with a damage-resistant powder coating for maximum longevity. Perfect for long-time brand enthusiasts, this premium, highly collectible edition is available just in time for holiday giving.
- CRAFTY+, $279
The CRAFTY+ model features a USB-C socket which reduces charging time by 25 minutes and a ceramic-coated filling chamber to make it even more resistant to scratches and damages.
- MIGHTY+, $399
The MIGHTY+ vaporizer features a USB-C socket and super-charge functionality delivering 80% charge in 40 minutes, a pre-set Superbooster temperature, and a 60-second rapid heat up time. The optimized design includes a hands-free stand and ceramic-coated filling chamber to make it even more resistant to scratches and damages.
- Notice Regarding Forward Looking Statements
This press release contains “forward-looking statements” and “forward-looking information” within the meaning of applicable U.S. and Canadian securities laws (collectively, “forward-looking statements”), which involve certain known and unknown risks and uncertainties. Forward-looking statements predict or describe our future operations, business plans, business and investment strategies and the performance of our investments. These forward-looking statements are generally identified by their use of such terms and phrases as “intend,” “goal,” “strategy,” “estimate,” “expect,” “project,” “projections,” “forecasts,” “plans,” “seeks,” “anticipates,” “potential,” “proposed,” “will,” “should,” “could,” “would,” “may,” “likely,” “designed to,” “foreseeable future,” “believe,” “scheduled” and other similar expressions. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date the statement was made. Forward–looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management, are inherently subject to significant business, economic and competitive risks, financial results, results, performance or achievements expressed or implied by those forward–looking statements and the forward–looking statements are not guarantees of future performance. Accordingly, there are or will be important factors that could cause actual outcomes or results to differ materially from those indicated in these statements. A discussion of some of the material factors applicable to Canopy Growth Corporation (“Canopy”) can be found under the section entitled “Risk Factors” in Canopy’s Annual Report on Form 10-K for the year ended March 31, 2021, filed with the Securities and Exchange Commission and with applicable Canadian securities regulators, as such factors may be further updated from time to time in its periodic filings with the Securities and Exchange Commission and with applicable Canadian securities regulators, which can be accessed at www.sec.gov/edgar and www.sedar.com, respectively. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in this press release and in the filings. Any forward–looking statement included in this press release is made as of the date of this press release and, except as required by law, Canopy disclaims any obligation to update or revise any forward–looking statement. Readers are cautioned not to put undue reliance on any forward–looking statement. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement.
(This information is primarily sourced from STORZ & BICKEL GmbH. Highly Capitalized has neither approved nor disapproved the contents of this news release. Read our Disclaimer here).
Reunion Neuroscience to be Acquired by MPM BioImpact in $13.1 Million All-Cash Deal
LOS ANGELES-- Reunion Neuroscience Inc. a clinical-stage biopharmaceutical company specializing in innovative therapies for underserved mental health conditions, has announced a definitive arrangement agreement with MPM BioImpact, a leading biotechnology investment firm. Under the agreement, ...
California’s Regulated Cannabis Market Sees Decline in Sales and Tax Revenue in Q1 2023
LOS ANGELES-- California's hopes of increased consumer participation in the regulated cannabis market did not translate into a boost in licensed retail sales or state tax revenue during the first quarter of 2023. According to ...
C21 Investments Repays $30 Million Debt to CEO Sonny Newman
LOS ANGELES-- C21 Investments Inc., a vertically integrated cannabis company, announced today the successful completion of the full repayment of its $30 million senior secured note owed to Sonny Newman, the Company's President and Chief ...